Search results
Study provides a blueprint of tumor-infiltrating B cells with therapeutic implications
Medical Xpress· 21 hours agoIn a study published in Science on May 3, researchers unveiled two responding patterns of tumor-infiltrating B cells with therapeutic implications.
Researchers find B cells drive responses of other immune cells, can be modified to prevent multiple...
Medical Xpress· 21 hours agoAn emerging class of drugs, called Bruton's tyrosine kinase (BTK) inhibitors may alter this abnormal B cell respiration and stop the signaling that leads to MS flare-ups.
Solvias to Build Biologics and Cell & Gene Therapy Testing Center in Research Triangle Park
CBS 47 Fresno· 21 hours agoIt is the company's latest investment to expand its analytical testing services supporting life science organizations with the growing number of cell and ...
Geologists, biologists unearth the atomic fingerprints of cancer
Phys.org· 15 hours agoIn a case of medicine meets Earth science, the researchers discovered that cancer cells may be made...
Nationally Recognized Life Sciences Patent Litigation Team Joins Mintz
LawFuel· 6 hours agoA leading life sciences patent litigation team has joined Mintz. The team is led by Siegmund (“Sige”) Gutman, who will serve as Member, Chair of Life Sciences< ...
Engineering Life: Chemists Have Created the Functional Synthetic Cells That Act Like Real Ones
SciTechDaily· 3 days ago“With this discovery, we can think of engineering fabrics or tissues that can be sensitive to...
Life sciences firm picks Triangle over Boston, Philly for 170-job facility - Triangle Business...
The Business Journals· 21 hours agoA European life sciences company is establishing operations in Morrisville with plans to fill more...
Earnings call: Vertex Pharmaceuticals reports solid Q1 growth, plans expansion By Investing.com
Investing.com· 1 hour agoThe company's financial performance was bolstered by the successful launch of CASGEVY in sickle cell...
Scientists Track ‘Doubling’ in Origin of Cancer Cells
Newswise· 5 days agoThe findings, published May 3 in Science, reveal what goes wrong when a group of molecules and enzymes trigger and regulate what’s known as the “cell cycle ...
Gilead Sciences Unusual Options Activity For May 06 - Gilead Sciences (NASDAQ:GILD)
Benzinga· 15 hours agoGilead Sciences's Current Market Status Trading volume stands at 3,631,936, with GILD's price up by 0.63%, positioned at $65.19. RSI indicators show the stock to be may be ...